New York · Seed–Late Stage · 5 people tracked
Also known as ALLY BRIDGE GROUP (NY) LLC · ALLY BRIDGE GROUP (PE) LLC
Investment thesis
Ally Bridge Group is a global healthcare investment manager targeting high-impact life sciences innovation in both private and public markets. Combining scientific and clinical research with M&A and capital markets expertise, the firm seeks investment opportunities across the capital structure that address unmet medical needs. It operates a public equity strategy alongside private investments, backing biotech and life sciences companies developing next-generation therapies.
Source: firm website, verified Aug 18, 2026.
Team · 5 people
from the firm's websiteWhat they invest in
from 14 of 16 portfolio companiesHealthtech ×12Biotech ×8Medical Devices ×7Digital Health ×4SaaS ×3Deep Tech ×2Fintech ×1Future of Work ×1
HQs:United States×8Canada×1France×1
Investments · 16 tracked
founders shown can be your intro pathAadi Bioscience develops therapies targeting mTOR-driven diseases using precision medicine and albumin-bound nanoparticle technology, applying genomic profiling to identify patients most likely to benefit from mTOR inhibition.
BiotechHealthtechMorristown, US
Scott Giacobello(Executive Officer)Bryan Ball(Executive Officer)Dave Lennon(Executive Officer, Director)David Dornan(Executive Officer)James Murphy(Executive Officer)Stephen Pakola(Executive Officer)
Co-investors3B Future Health FundDecheng CapitalVivo CapitalAvoro VenturesOrbiMed
SetPoint Medical develops a device-based neuroimmune modulation therapy that stimulates the vagus nerve to treat chronic autoimmune conditions, with its first indication being moderate-to-severe rheumatoid arthritis in the US.
BiotechDigital HealthHealthtechMedical DevicesValencia, US
Murthy Simhambhatla(CEO)David Chernoff(Chief Medical Officer (MD))Yaakov Levine(PhD)
Co-investorsNorwest Venture PartnersNew Enterprise Associates (NEA)Topspin PartnersCatalio Capital Management, LPCitta CapitalLightstone Ventures+4 more
AdvanCell is a clinical-stage radiopharmaceutical company developing a pipeline of targeted alpha therapies for the treatment of cancers including prostate, melanoma, ovarian, breast, and lung.
BiotechHealthtechMedical DevicesCambridge, US
Andrew Adamovich(Director)Philina Lee(Executive Officer, Director)Aaron Pickett(Executive Officer)
BoardWing Cheong Lam(Director)Nik Economopoulos(Director)Anthony Aiudi(Director)
Co-investorsBain Capital Life SciencesCatalio Capital Management, LPProto AxiomSV Health InvestorsTenmileAbingworth+1 more
Developer of an FDA-cleared, patch-worn, cuff-less 24-hour ambulatory blood pressure monitoring system for hypertension diagnosis and treatment.
Biobeat offers a wearable chest-patch device paired with a mobile app for 24-hour ambulatory blood pressure monitoring to confirm or unmask hypertension.
Digital HealthHealthtechMedical Devices
Co-investorsOrbiMedRaptor Group
Calyxo develops medical devices for kidney stone removal, specifically a minimally invasive CVAC (Cavitation-Enabled Ablation and Clearance) system that has been FDA-cleared.
HealthtechMedical DevicesPleasanton, US
Chris Buchko(Executive Officer)Douglas Hughes(Executive Officer, Director)Jee Shin(Executive Officer, Director)Mark Kidd(Executive Officer)Joe Catanese(Executive Officer, Director)
BoardRyan Drant(Director)in
Co-investorsQuesta CapitalJanus Henderson Investors
Cardiac Dimensions develops the Carillon Mitral Contour System, an implantable device therapy for treating functional mitral regurgitation (FMR) in heart failure patients.
BiotechHealthtechMedical DevicesKirkland, US
Kurt Wheeler(Director)Frederick A. Stewart(Executive Officer, Director)Richard O. Martin(Director)Nathan Every(Director)Douglas C. Fisher(Director)Gerry Brunk(Director)
Co-investorsAPERTURE Venture PartnersLumira VenturesRedbus Ventures
Climb is a French wealth management service that combines advisors with technology to grow clients' assets through an open-architecture selection of investment products (life insurance, retirement PER, real estate, private equity, tax-reduction schemes, crypto).
FintechSaaS
Aldric Emié(CEO)
Co-investorsKima VenturesRA CapitalREDMILE
Elevage Medical Technologies provides capital investment and strategic operational support to growth-stage medtech companies, focusing on FDA-regulated medical devices and diagnostics, lab tools, and healthcare IT and tech-enabled services.
Digital HealthHealthtechMedical Devices
Epicrispr Biotechnologies develops therapies that dynamically control gene expression using the epigenome to treat complex diseases.
BiotechDeep TechHealthtech
Galvanize Therapeutics develops surgical ablation technology using its proprietary Aliya Pulsed Electric Field (PEF) energy to destroy soft tissue cells through regulated cell death mechanisms.
BiotechHealthtechMedical DevicesRedwood City, US
Doug Godshall(Executive Officer, Director)Steve Anheier(Executive Officer)
BoardJonathan Waldstreicher(Executive Officer)Antoine Papiernik(Director)inSeth Harrison(Director)Zack Scott(Director)
Co-investorsATPFidelity InvestmentsGilmartin Capital LLCNorwest Venture PartnersPerceptive Xontogeny VentureSofinnova Partners
Chronus (at imperative.com) offers an AI-assisted mentoring and connection platform that matches employees for guided conversations covering career development, mentorship, community building, and change adoption.
Future of WorkHR TechSaaSNew York, US
Co-investorsVoyager CapitalBain Capital Life SciencesCatalio Capital Management
OrbiMed is a healthcare-focused investment firm that provides financing across the healthcare industry, including biopharmaceuticals, medical devices, digital health, diagnostics, and healthcare services.
BiotechHealthtech
ProMIS Neurosciences is a clinical-stage biotechnology company developing antibody therapeutics that target toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's, ALS, and Parkinson's.
BiotechDeep TechHealthtechToronto, CA
EUGENE WILLIAMS(Director)ELLIOT GOLDSTEIN(Executive Officer, Director)WARREN WHITEHEAD(Executive Officer)PATRICK KIRWIN(Director)NEIL CASHMAN(Executive Officer, Director)WILLIAM WYMAN(Director)
Vida Health delivers personalized, human-centered digital health care addressing both physical and mental health.
Digital HealthHealthtechSaaSSan Francisco, US
Joe Murad(CEO)Mike Rolla
BoardRichard Frank
Co-investorsAspect VenturesCanvas VenturesGeneral AtlanticHLM Venture PartnersOwl CapitalWebb Investment Network+2 more
Exits · 1
IPOs and acquisitions across the tracked portfolioAadi BioscienceNASDAQ: WHWK
Portfolio news
latest coverage across their companiesClimb · bloomberg.com · Aug 12, 2026
AdvanCell · intelligence360.news · Aug 4, 2026
Calyxo · calyxoinc.com · May 8, 2026
Vida Health · finsmes.com · Nov 13, 2025
Galvanize Therapeutics · fiercebiotech.com · Sep 4, 2025
Cardiac Dimensions · geekwire.com · Mar 24, 2025
Frequently asked questions
- How many investments has Ally Bridge Group made?
- Ally Bridge Group has 10 tracked investments.
- What stage does Ally Bridge Group invest at?
- Ally Bridge Group invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
- What sectors does Ally Bridge Group focus on?
- Ally Bridge Group focuses on Biotech, Digital Health, Healthtech, Longevity, Medical Devices.
- Where is Ally Bridge Group located?
- Ally Bridge Group is headquartered in New York, US.
- Does Ally Bridge Group lead rounds?
- Yes, Ally Bridge Group leads investment rounds.
- Who does Ally Bridge Group co-invest with?
- Ally Bridge Group most often shares deals with Aspect Ventures, Canvas Ventures, Lightstone Ventures, among 17 tracked co-investors.
Media · Podcasts & interviews
featuring the teamKevin Reilly, Ally Bridge Group | theCUBE + NYSE Wired MedTech Unplugged Series
SiliconANGLE theCUBE · Kevin Reilly
Frank Yu | Ally Bridge Group @ The Hellenic Museum, Melbourne
River X · Frank Yu
Talking Money To Us | Frank Yu - Ally Bridge Group & Julius Garofali - Shaw and Partners - Talk Money To Me | Acast
Frank Yu · shows.acast.com
Similar investors
Lumira Ventures is a North American life sciences venture capital firm that partners with mission-driven entrepreneurs to build companies developing and commercializing healthcare products for patients.
Foresite Capital is a multi-stage investment firm focused on healthcare and life sciences, backing companies across all stages of growth. It applies a data science-driven approach to invest in businesses leveraging biology and big data to transform healthcare.
Advent Life Sciences is a trans-Atlantic venture capital firm investing in early and mid-stage life sciences companies across the UK, Europe and the USA.
InVivium Capital is a healthcare-focused investment firm backing transformative life sciences and healthcare innovation, partnering with founders to bring new technologies to life.
SV Health Investors is a healthcare-focused private equity and venture capital investment platform managing specialized and diversified funds across biotechnology, healthcare growth equity, and medtech.